Imran Khan received PhD fellowship from German Academic and Exchange Service (DAAD) for his doctoral study at Institute for Molecular Biotechnology, RWTH Aachen University, Germany. He also served Vienna Institute for Biotechnology, Vienna, Austria, as researcher where he investigated expression and targeting of recombinant proteins in plant tissues. He also received research funding as PI and supervised PhD and master students working as Assistant Professor at Center for Interdisciplinary Research, Islamabad, Pakistan. He completed his postdoctoral study from University of Bonn, Germany that was also funded by DAAD, Germany. In 2019, Imran received Penn Biomedical Postdoctoral fellowship for postdoctoral study at School of Dental Medicine at University of Pennsylvania, Philadelphia, USA, where he worked on oral delivery of plant made biopharmaceuticals using Chloroplast production system, in collaboration with Takeda, Japan. He joined Dr. McDonald/Nandi lab in 2021 at University of California, Davis, USA, as Assistant Project Scientist. His current research focus on development of platform technologies for bio-manufacturing on Mars to provide food and pharmaceuticals for colonists, funded by National Aeronautics and Space Administration (NASA), USA.